跳至主要内容
临床试验/NCT02818790
NCT02818790已完成不适用

PREventive Care Infrastructure Based On Ubiquitous Sensing (PRECIOUS)

Hospital Universitari Vall d'Hebron Research Institute2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2016年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
2
主要终点
Patients' subjective assessment of usability of the PRECIOUS system

研究概览

简要总结

The goal of the MI field test is to assess users' overall satisfaction, usability and acceptability of the PRECIOUS system, and to explore if MI in combination with gamification principles is a feasible solution to foster adherence to PRECIOUS system. Moreover, it is pursued to trigger behavior change and build up motivation to maintain sustained change towards healthy lifestyles. The field test at University Hospital Vall d'Hebron will be carried out with morbidly obese pre-diabetic patients. This pilot test will serve to explore users' acceptance of PRECIOUS system in an early stage of its development. Considering that this is a pilot test, feedback and outcomes obtained will serve to refine and adjust PRECIOUS system concept and architecture.

详细描述

The pilot test will recruit 30 morbidly obese pre-diabetic patient and they will be randomized into three groups: Group 1. Treatment as usual; Group 2. PRECIOUS system; Group 3. PRECIOUS system and Motivational Interviewing counseling. Researchers of this study will contact telephonically with potential participants and will ask for voluntary participation. Among those who agree, a face-to-face appointment at the reference hospital will be scheduled. In this appointment, general information on the study objectives and procedures will be offered.

The length of intervention will be 3 months with the following scheduled follow-up appointments: week 2 (considering baseline as week 1), week 5, week 8 and week 12. In the follow-up appointments 2, 5 and 8, only doubts and questions regarding system use will be addressed (not specific measures will be collected). Two types of measures will be assessed: 1) Primary outcome measures (at the end of the test) to assess usability, satisfaction, user's acceptance, and effectiveness of PRECIOUS system; and 2) Secondary outcome measures (baseline and final assessment) to assess different aspects of lifestyle and health habits. In addition, all patients will use a device to record heart rate during 3 consecutive days (week 1 and 12).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients must be under the care of medical specialists who adheres to national guidelines for morbid obesity or pre-diabetic conditions.
  • Age older than 18 years.
  • Body max index (BMI): ≥ 30 mg/m
  • Pre-diabetic condition following ADA criteria: fasting plasma glucose level from 5.6mmol/L (100 mg/dL) to 6.9mmol/L (125 mg/dL).
  • Patients must be able to participate, understand and complete questionnaires in Spanish language.
  • Patients must refer to be used to use multimedia platforms such as PDAs, tablets, laptops, smart phones or personal computers in a regular basis.

排除标准

  • Any mental (e.g. cognitive impairment, severe psychopathology not stabilized) or physical condition that could interfere with the successful application of the research protocol.
  • Patients will be recruited from specialist outpatient consultation at Vall d'Hebron Research Institute (VHIR). All patients must be under the care of specialists who adhere to national guidelines.

结局指标

主要结局

Patients' subjective assessment of usability of the PRECIOUS system

时间窗: At the end of the test (Session 5, week 12)

o Numeric scale 0-10 \& 10 items, 5-point Likert Scale, 0-100

Satisfaction with the PRECIOUS system

时间窗: At the end of the test (Session 5, week 12)

o 16 Numeric scales 0-10

User's acceptance of the PRECIOUS system

时间窗: At the end of the test (Session 5, week 12)

o 4 Numeric scales 0-10, based on QUIS7

Effectiveness of the PRECIOUS system

时间窗: At the end of the test (Session 5, week 12)

o Difference between the control group and the intervention groups regarding engagement and adherence to targeted healthy habits based on MCID between groups of the PRECIOUS system.

次要结局

  • Demographics and clinical data(Session 1 (week 1) and Session 5 (week 12))
  • Health-related quality of life(Session 1 (week 1) and Session 5 (week 12))
  • Weight management(Session 1 (week 1) and Session 5 (week 12))
  • Severity of the core symptoms of Depression, Anxiety & Stress(Session 1 (week 1) and Session 5 (week 12))
  • Physical activity(Continuous measure (intervention groups))
  • Nutritional habits(Continuous measure (intervention groups))
  • Alcohol consumption(Session 1 (week 1) and Session 5 (week 12))
  • Tobacco use(Session 1 (week 1) and Session 5 (week 12))
  • Sleep quality(Session 1 (week 1) and Session 5 (week 12))
  • Assessment of the motivational aspects of PRECIOUS(Session 5 (week 12) Intervention groups)
  • Bodyguard 2 device(Session 1 (week 1) and Session 5 (week 12))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验